Intertek has acquired an Automated Breathing Metabolic Simulator from ATOR Labs to enhance its respiratory product testing capabilities, solidifying its leadership in the market.

Information on the Target

Intertek has acquired an Automated Breathing Metabolic Simulator (ABMS) from ATOR Labs to enhance its respiratory product testing capabilities. This apparatus, one of only nine operational globally, equips Intertek with state-of-the-art technology, enabling it to offer precise testing and compliance solutions for respirator manufacturers. With the ability to accurately simulate human breathing and metabolic processes, the ABMS supports rigorous evaluations of respiratory protective devices (RPDs), such as respirators, self-contained breathing apparatus (SCBA), and powered air-purifying respirators (PAPR).

ATOR Labs, the creator of the ABMS, is recognized as a pioneer in the field of respiratory protective device testing equipment. Their systems are designed to emulate various respiratory workloads and ventilation rates, thereby ensuring thorough testing under realistic conditions. This capability is crucial as the demand for reliable respiratory protection continues to grow across multiple industries, including healthcare, firefighting, and emergency response.

Industry Overview in the Target's Specific Country

The industry surrounding respiratory protective devices is expanding rapidly, driven by increased awareness of health and safety protocols in various sectors. In the United States, regulations governing respiratory products are str